Nursing in the News

Public health funding at risk

RNAO CEO Doris Grinspun joined a number of health-care professionals at a media event May 13 to call for a stop to planned cuts to public health that were part of the provincial government’s first budget, released in April.

Nursing Notes

Leadership award for former RNAO president

In June, Vanessa Burkoski received a 2019 Nursing Leadership Award from the Canadian College of Health Leaders.

Nursing Notes

Recognizing work  with Indigenous communities

 In May, RNAO member Barathi Vengadasamy received an Indigenous Services Canada  Award of Excellence in Nursing.

Nursing Notes

Workplace violence BPG launches

The second edition of RNAO’s best practice guideline (BPG) on violence, harassment and bullying against health workers is now available online.

Nursing Notes

NP represents Canada on international board

NP and former RNAO policy analyst Valerie Rzepka (far right) has joined the board of directors of the World Association for Disaster and Emergency Medicine (WADEM) Nursing Special Interest Group.

BPG Corner

Newest BPSO cohort

In April, RNAO honoured its newest cohort of BPSOs in long-term care representing 18 nursing homes, and one organization in Jamaica. 

BPG Corner

Ostomy guideline marks milestone

In April, RNAO released Supporting Adults Who Anticipate or Live with an Ostomy, the next edition of the 2009 best practice guideline (BPG), Ostomy Care and Management.

BPG Corner

Francophone first

RNAO has named its first Best Practice Spotlight Organization (BPSO) Host that will be responsible for bringing francophone organizations into the BPSO movement.

Nursing Notes

Studying the science of cannabis

Beginning in May, 2019, McMaster University will offer a new, three-course certificate program – one of the first in Canada – focused on the science of cannabis.

Nursing Notes

Hoskins’ interim pharmacare report 

In March, the federal government’s Advisory Council on the Implementation of National Pharmacare released its interim report, which included three recommendations: create a national drug agency; develop an evidence-based list of prescribed drugs; and invest in drug data and information technology